Home | Welcome to Contract Pharma   
Last Updated Saturday, November 1 2014
Print

Trials & Filings in Brief: Jan. 7, 2014



By Gil Roth



Published January 7, 2014
Related Searches: contractpharma www.contractpharma.com Phase III Phase II
Phase II
Erytech to begin pancreatic cancer study . . . read more

Galena enrolls first ovarian cancer patient . . . read more

Neurocrine Biosciences posts positive results in tardive dyskinesia . . . read more

TeaRx begins anticoagulant trial . . . read more

Phase III
Positive results for Shield's IDA treatment in IBD . . . read more

Approvals
Celgene's Abraxane approved in EU for pancreatic cancer . . . read more

Filings
Alitair gets orphan status for bronchiectasis treatment . . . read more

Orexigen gets Contrave PDUFA date . . . read more


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On